|
Kibow Biotech
|
|
Kibow Biotech is a company based in Philadelphia that is researching and developing dietary supplements. History *1997 - Founding of Kibow *1998 - RnD begins, Advisory Board Set up *2001 - First NIH grant received (drug development) *2002 - Second NIH grant received (dietary supplement development) *2003 - 5 Trademarks obtained *2004 - 2 US patents approved *2005 - 1 US patent approved *2006 - Positive Proof of efficacy from cats and dogs with kidney failure. Licensing of product Azodyl to Vetoquinol *2007 - 3 patents approved in Australia, China, India. Clinical trials initiated in Canada, USA, Nigeria, Argentina *2009 - Launched of Human Product Kibow Biotics, Clinical trial paper publish in Current Medical Research and Opinion Management Jack Dickstein, Ph.D. - President Emeritus Natarajan Ranganathan, Ph.D. - Interim CEO, Senior Vice President (R&D) Jay Ram - Vice President (Business Development and Strategic Operations) Mary Galambert - Vice President (Marketing and Communications) Pari Ranganathan - Vice President (Clinical and Regulatory) 
|
| < Prev | Next > |
|---|
Main Menu
| Home |
| Articles |
| Search |
| Submit Article |
| Contact Us |
| Donate to Wikibin |
